T
Talis Biomedical Corp
NASDAQ:TLIS
Talis Biomedical Corp
NASDAQ:TLIS
Price:
2.84
USD
Market Closed
Market Cap:
$5.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
US |
|
Surgical Science Sweden AB
OTC:SUSRF
|
SE |
|
C
|
CammSys Corp
KOSDAQ:050110
|
KR |
|
Associated British Foods PLC
LSE:ABF
|
UK |
|
Al Yamamah Steel Industries Company CJSC
SAU:1304
|
SA |
|
L
|
LFM Properties Corp
XPHS:LPC
|
PH |
|
Zhejiang Publishing & Media Co Ltd
SSE:601921
|
CN |
|
I
|
Immsi SpA
MIL:IMS
|
IT |
|
Z
|
Zumtobel Group AG
VSE:ZAG
|
AT |
|
B
|
Best World International Ltd
SGX:CGN
|
SG |
|
Asahi Group Holdings Ltd
TSE:2502
|
JP |
|
Arena Reit No 1
ASX:ARF
|
AU |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TLIS's stock price target?
Not Available
TLIS doesn't have any price targets made by Wall Street professionals.
What is Talis Biomedical Corp's Revenue forecast?
Projected CAGR
149%
149%
For the last 4 years the compound annual growth rate for Talis Biomedical Corp's revenue is -14%. The projected CAGR for the next 2 years is 149%.
